₹120.6
▲ +1.55 +1.30%
16 Jun 2026
BSE Listed · Pharmaceuticals
Panchsheel Organics Ltd. (531726)
Volume: 4,588Avg Vol 1W: 6,414Avg Vol 1M: 18,09652W Range:₹90.2₹179
Key Ratios
Updated just nowMarket Cap—
Current Price₹120.6
Previous Close₹119.05
High / Low (52w)₹179 / ₹90.2
Volume4,588
Avg Vol (1W)6,414
Avg Vol (1M)18,096
Stock P/E12.91
Book Value₹106.93
Dividend Yield—
ROE10.65%
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹1.29
P/B1.13
Debt / Equity0.05
50 DMA₹121.81
200 DMA₹126.04
Day change+1.30%
Price Chart
₹120.6▼ 18.51% · 1Y
2025-06-172026-06-16
20-day avg volume: 17K shares
Pros
- Company is almost debt-free.
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sept 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sept 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹31 Cr | ₹27 Cr | ₹25 Cr | ₹24 Cr | ₹28 Cr | ₹26 Cr | ₹27 Cr | ₹26 Cr | ₹31 Cr | ₹26 Cr | ₹24 Cr | ₹25 Cr | ₹30 Cr | ₹28 Cr | ₹24 Cr | ₹21 Cr | ₹23 Cr | ₹16 Cr | ₹15 Cr | ₹16 Cr | ₹12 Cr | ₹12 Cr | ₹15 Cr | ₹10 Cr | ₹12 Cr |
| EBITDA | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Net Profit | ₹2 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
| EPS | 1.29 | 2.79 | 1.98 | 2.16 | 2.41 | 2.79 | 2.88 | 2.6 | 2.11 | 2.85 | 2.47 | 2.59 | 2.27 | 2.98 | 3.41 | 3.48 | 3.3 | 2.02 | 1.61 | 3.38 | 1.85 | 1.46 | 3.28 | 2.03 | 2.65 |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Revenue | ₹110 Cr | ₹108 Cr | ₹104 Cr | ₹69 Cr | ₹50 Cr | ₹51 Cr |
| EBITDA | ₹18 Cr | ₹20 Cr | ₹20 Cr | ₹12 Cr | ₹8 Cr | ₹8 Cr |
| Net Profit | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹8 Cr | ₹5 Cr | ₹5 Cr |
| EPS | 10.47 | 10.71 | 11.94 | 8.33 | 9.98 | 10.55 |
Balance Sheet
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Total Assets | ₹163 Cr | ₹159 Cr | ₹123 Cr | ₹74 Cr | ₹58 Cr | ₹52 Cr |
| Total Liabilities | ₹29 Cr | ₹34 Cr | ₹27 Cr | ₹27 Cr | ₹18 Cr | ₹17 Cr |
| Equity | ₹134 Cr | ₹125 Cr | ₹96 Cr | ₹47 Cr | ₹40 Cr | ₹35 Cr |
| Total Debt | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr |
Cash Flow
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Operating | ₹8 Cr | ₹15 Cr | ₹6 Cr | ₹1 Cr | ₹8 Cr |
| Investing | ₹-16 Cr | ₹-7 Cr | ₹-34 Cr | ₹0 Cr | ₹-1 Cr |
| Financing | ₹-5 Cr | ₹16 Cr | ₹36 Cr | ₹-1 Cr | ₹-2 Cr |
| Free Cash Flow | ₹8 Cr | ₹15 Cr | ₹6 Cr | ₹1 Cr | ₹8 Cr |
Shareholding
Promoter 56.12% Institutions 0% Public 43.88%
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search